Health

• The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products (03 Sep 2024)
  
• Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation (03 Sep 2024)
  
• Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial (03 Sep 2024)
  
• Trends of emergency department visits for cannabinoid hyperemesis syndrome in Nevada: An interrupted time series analysis (02 Sep 2024)
  
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England (02 Sep 2024)
  
• The impact of recreational cannabinoid legalization on utilization in a pregnant population (02 Sep 2024)
  
• Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products (02 Sep 2024)
  
• Prenatal cannabinoid exposure and early language development (02 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Tr (02 Sep 2024)
  
• Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain (02 Sep 2024)
  
• Cannabis Hyperemesis Syndrome: What Do We Know? (02 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety – Pennsylvania, March 2023–April 2023 (02 Sep 2024)
  
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic (02 Sep 2024)
  
• cancer pain: an analysis of pain mechanism and cannabinoid profile (30 Aug 2024)
  
• Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder (29 Aug 2024)
  
• Influence of Cannabinoid Treatment on Trajectories of Patient-Related Outcomes in Chronic Pain: Pain Intensity, Emotional Distress, Tolerability and Physical Disability (29 Aug 2024)
  
• Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (29 Aug 2024)
  
• CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure (29 Aug 2024)
  
• Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review (29 Aug 2024)
  
• Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents (28 Aug 2024)
  
• CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
  
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease (27 Aug 2024)
  
• Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach (27 Aug 2024)
  
• Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (27 Aug 2024)
  
• Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department (27 Aug 2024)
  
• Cannabinoid Conference 2022 (27 Aug 2024)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report (25 Aug 2024)
  
• A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ (25 Aug 2024)
  
• A bibliometric analysis of the cannabis and cannabinoid research literature (25 Aug 2024)
  
• The cannabinoid receptor-1 gene interacts with stressful life events to increase the risk for problematic alcohol use (21 Aug 2024)
  
• Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis (21 Aug 2024)
  
• Safety Considerations in Cannabinoid-Based Medicine (20 Aug 2024)
  
• Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting (20 Aug 2024)
  
• Medicinal Cannabis and Synthetic Cannabinoid Use (20 Aug 2024)
  
• Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes (20 Aug 2024)
  
• Cannabis and cannabinoid use in autism spectrum disorder: a systematic review (20 Aug 2024)
  
• Cannabinoid treatment for autism: a proof-of-concept randomized trial (20 Aug 2024)
  
• Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report (20 Aug 2024)
  
• A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid (20 Aug 2024)
  
• Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective (18 Aug 2024)
  
• Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (18 Aug 2024)
  
• Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (18 Aug 2024)
  
• First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (12 Aug 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use (24 May 2024)
  
• Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a rando (24 May 2024)
  
• An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies (24 May 2024)
  
• Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain (13 May 2024)
  
• Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates (13 May 2024)
  
• A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation (13 May 2024)
  
• Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
  
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry (05 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
  
• New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
  
• Enhancing Endocannabinoid Control of Stress with Cannabidiol (27 Aug 2022)
  
• Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• The Transdermal Delivery of Therapeutic Cannabinoids (05 Aug 2022)
  
• Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
  
• Comparison of nabiximols versus oral dronabinol for pain (05 Aug 2022)
  
• Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders (05 Aug 2022)
  
• The Effects of Consuming Cannabis Flower for Treatment of Fatigue (31 Jul 2022)
  
• Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Medical cannabis in treating patients with sleep disorders (31 Jul 2022)
  
• Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)
  
• Cannabinoids for the Treatment of Dermatologic Conditions (31 Jul 2022)
  
• Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report - Journal of Medical Case Reports (31 Jul 2022)
  
• Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• What are the informational pathways that shape people’s use of cannabidiol for medical purposes? - Journal of Cannabis Research (26 Jul 2022)
  
• The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients - Journal of Cannabis Research (26 Jul 2022)
  
• The therapeutic role of Cannabidiol in mental health: a systematic review - Journal of Cannabis Research (26 Jul 2022)
  
• Staff awareness of the use of cannabidiol (CBD): a trust-wide survey study in the UK - Journal of Cannabis Research (26 Jul 2022)
  
• Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users - Journal of Cannabis Research (26 Jul 2022)
  
• Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems - Journal of Cannabis Research (26 Jul 2022)
  
• Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations - Journal of Cannabis Research (26 Jul 2022)
  
• Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists - Journal of Cannabis Research (26 Jul 2022)
  
• Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series - Journal of Cannabis Research (26 Jul 2022)
  
• Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review - Journal of Cannabis Research (26 Jul 2022)
  
• Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial - Sports Medicine - Open (26 Jul 2022)
  
• Delta-8-THC: Delta-9-THC’s nicer younger sibling? - Journal of Cannabis Research (26 Jul 2022)
  
• CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
  
• Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic - Journal of Cannabis Research (26 Jul 2022)
  
• A content analysis of internet information sources on medical cannabis - Journal of Cannabis Research (26 Jul 2022)
  
• A bibliometric analysis of the cannabis and cannabinoid research literature - Journal of Cannabis Research (26 Jul 2022)
  
• Study Shows Cannabinoids May Help With Pathological Tremors (25 Jul 2022)
  
• Study reveals antibiotic potential of cannabis compound (25 Jul 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Bod Australia to start long Covid-19 trial using medicinal cannabis in UK (25 Jul 2022)
  
• Research Breakthrough: Cannabis & Autism (21 Jul 2022)
  
• Medical Uses of CBD (21 Jul 2022)
  
• ICRS 2019: CBD for Anxiety, Cancer, Heart Disease, Addiction... (21 Jul 2022)
  
• Gut Microbiota & the Endocannabinoid System (21 Jul 2022)
  
• Encouraging Cancer Research (21 Jul 2022)
  
• CBD User's Guide (21 Jul 2022)
  
• CBD & Its Entourage (21 Jul 2022)
  
• CBD Dentistry (21 Jul 2022)
  
• CBD & Cannabis for Endometriosis (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabis and Cancer Part 2: Scientists Look for Ways to Increase Knowledge About Cannabis with Help from People with Cancer (21 Jul 2022)
  
• Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used (21 Jul 2022)
  
• A mixed methods analysis of cannabis use routines for chronic pain management - Journal of Cannabis Research (21 Jul 2022)
  
• What is CBD? Definition of Cannabidiol & CBD Oil (20 Jul 2022)
  
• The Science of Cannabinoids (20 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• How to use CBD & Cannabis (20 Jul 2022)
  
• CBIS Cannabinoid Research (20 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• What Is HHC? (18 Jul 2022)
  
• What Is CBC Oil Good For? Benefits, Uses, & Effects (18 Jul 2022)
  
• What is Cannabichromene (CBC)? Benefits, Uses, Dosages (18 Jul 2022)
  
• What are cannabinoids CBN, CBC, CBG and THCV? (18 Jul 2022)
  
• Very high doses of CBD, a cannabis component, don’t affect driving (18 Jul 2022)
  
• Top Delta-8 THC Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBN (Cannabinol) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBL Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBGA Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBG (Cannabigerol) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBDA (Cannabidiolic Acid) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBD (Cannabidiol) Questions Answered by CBD Science (18 Jul 2022)
  
• The Science Behind CBD's Effects on the Brain and Body (18 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)
  
• Substance analogous to cannabidiol can enhance chemotherapy by preventing neuropathic pain (18 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)
  
• Some cannabis products associated with short-term chronic pain improvements, but side effects a concern (18 Jul 2022)
  
• Prescribed CBD could help people quit cannabis (18 Jul 2022)
  
• Pioneering clinical trial to treat psychosis in Parkinson's patients using cannabidiol (18 Jul 2022)
  
• Pharma aims to make a better CBD (18 Jul 2022)
  
• New study: Cannabis helps fight resistant bacteria (18 Jul 2022)
  
• New insight into how cannabidiol takes effect in the brains of people with psychosis (18 Jul 2022)
  
• Medicinal cannabis may reduce behavioral problems in kids with intellectual disabilities (18 Jul 2022)
  
• Here’s the truth about CBD, from a cannabis researcher (18 Jul 2022)
  
• Guide to Cannabinoids: Understanding the Endocannabinoid System (18 Jul 2022)
  
• Epileptic seizure frequency fell by 86% in kids treated with whole plant medicinal cannabis (18 Jul 2022)
  
• Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression (18 Jul 2022)
  
• Daily CBD Routine: Top Ways to Use CBD Everyday (18 Jul 2022)
  
• Cresco Labs (18 Jul 2022)
  
• Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines (18 Jul 2022)
  
• CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)
  
• CBD reduces craving and anxiety in people with heroin use disorder (18 Jul 2022)
  
• CBD may help avert lung destruction in COVID-19 (18 Jul 2022)
  
• CBD Carrier Oils: Which is the Most Effective? (18 Jul 2022)
  
• CBD and THC are Safe Supplements to Opioid Treatment (18 Jul 2022)
  
• Cannabis study reveals how CBD offsets the psychiatric side-effects of THC (18 Jul 2022)
  
• Cannabis extract helps reset brain function in psychosis (18 Jul 2022)
  
• Cannabis compound acts as an antibiotic (18 Jul 2022)
  
• Cannabinoid Acids Breakthrough Study for COVID (18 Jul 2022)
  
• Cannabidivarin Definition (18 Jul 2022)
  
• Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows (18 Jul 2022)
  
• Animal study shows safety of using CBD and THC with opioids (18 Jul 2022)
  
• 10 CBD facts every user should know (18 Jul 2022)